Cigna Group (NYSE:CI) Insider Sells $5,369,583.72 in Stock

Cigna Group (NYSE:CIGet Free Report) insider Nicole Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Cigna Group Trading Up 1.8%

Cigna Group stock traded up $4.76 during midday trading on Thursday, reaching $275.26. The stock had a trading volume of 2,949,160 shares, compared to its average volume of 1,720,622. The stock has a market capitalization of $72.73 billion, a PE ratio of 11.39, a price-to-earnings-growth ratio of 0.94 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock’s 50-day simple moving average is $286.09 and its 200 day simple moving average is $281.17. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 25.82%.

Institutional Trading of Cigna Group

Several hedge funds have recently bought and sold shares of CI. Wilkerson Advisory Group LLC acquired a new position in Cigna Group during the 4th quarter valued at about $25,000. Cedar Mountain Advisors LLC increased its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the period. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc acquired a new position in shares of Cigna Group during the fourth quarter worth approximately $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in Cigna Group in the 2nd quarter worth approximately $34,000. 86.99% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on CI shares. Royal Bank Of Canada lifted their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $336.00 to $307.00 in a research report on Tuesday. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price objective for the stock from $350.00 to $320.00 in a research note on Monday. Finally, Barclays increased their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Read Our Latest Analysis on CI

Cigna Group Company Profile

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Insider Buying and Selling by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.